Hospital as Nexus of Innovation

Posted by healthblogger on 04/03/10

The ERRIN innovation event, The Hospital of the Future, 2 March 2010, explored the future of the hospital as a recipient of financially and environmentally sustainable investment. The key outcome for me, as one of the moderators of the event, was the emerging view of the hospital as a major innovator within their local/regional economies. [...]

Regional innovators, European disruptors, world-class leaders.

Posted by healthblogger on 07/12/09

We are all innovators now.  Gone, surely, must be the days of free-riders, of subsidised mediocrity and creative malaise. A new world beckons. But doubts remain. I had the privilege of moderating an excellent post-Lisbon event on innovation for ERRIN, the European Regions Research and Innovation Network.  What was so exciting was to hear from [...]

New directions for a productive and innovative European biopharma industry

Posted by healthblogger on 01/09/09

Recent research suggests that the European pharmaceutical industry is more productive than the US one.  Euractive reports on this here: article-184974. A few things to consider.  Light’s work is a reanalysis of existing data.  His conclusions are based on using the head-office of the company discovering the drug as determining the country of origin.  He [...]

Regional Advantage or Parochial Mediocrity?

Posted by healthblogger on 03/08/09

Annalee Saxenian, an astute observer and analyst of the regional advantage of Silicon Valley, observes in her book, The New Argonauts, that the Valley has gained as its home-grown entrepreneurs have built overseas businesses in China, India and elsewhere.  She notes: “By promoting the development of local capabilities in Tel Aviv,  Hsinchu, Shanghai, Bangalore, and [...]

Swedish Presidency: innovation

Posted by healthblogger on 26/06/09

Sweden is home to the Karolinska Institute, one of the most effective bio-medical institutions in the EU. The worst thing the EU could do would be to copy Sweden; they are exemplary. What should be left behind at the end of December is a commitment by member states to unleash the creativity in their research [...]

Into the valley of death rode … no-one? Where are Europe’s entrepreneurial investors?

Posted by healthblogger on 27/02/09

Considerable public funding goes into research.  To the dismay, though, of many, European countries in the main are very poor at commercialising this research, and thus return of this public investment is often zero euros. Reasons lie in at least two places: EU member states (outside of the ‘anglo’ tradition) tend to ‘own’ their own [...]

Greedy governments, poorer societies

Posted by healthblogger on 21/12/07

Greedy governments stifle innovation by reserving all the intellectual property of publicly funded research for their own use.  The problem is that governments are not very good at knowing what to do next, and invariably tie up valuable innovation in bureaucratic process, without adding any social value at all. The Eurocrats like US comparisons, so [...]

Euro-Sante :: Euro-Health rss

Mike Tremblay on innovation, life sciences & health. Click here to learn more.